» Articles » PMID: 38181303

Modifiable Lifestyle Factors, Genetic Risk, and Incident Peripheral Artery Disease Among Individuals With Type 2 Diabetes: A Prospective Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2024 Jan 5
PMID 38181303
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To prospectively evaluate the association between modifiable lifestyle factors and peripheral artery disease (PAD) among individuals with type 2 diabetes (T2D).

Research Design And Methods: We included 14,543 individuals with T2D from the UK Biobank. We defined a weighted healthy lifestyle score using nonsmoking, regular physical activity, high-quality diet, moderate alcohol consumption, optimal waist-to-hip ratio, and adequate sleep duration, and categorized into unfavorable, intermediate, and favorable lifestyles. We created a genetic risk score (GRS) using 19 single nucleotide polymorphisms previously found to be associated with PAD. We modeled the association between lifestyle score and PAD, overall and stratified by PAD genetic susceptibility.

Results: After a median 13.5 years of follow-up, 628 incident cases of PAD were documented. A linear inverse association between the weighted lifestyle score and PAD was observed, with a hazard ratio (HR) (95% CI) of 0.27 (0.19, 0.38) for favorable compared with unfavorable lifestyle (Ptrend < 0.0001). An estimated 58.3% (45.0%, 69.1%) of PAD in this population could be potentially avoidable if all participants attained a favorable lifestyle. Moreover, the PAD GRS was associated with increased PAD risk (HR [95% CI] per SD increment: 1.13 [1.03, 1.23]). A favorable lifestyle was able to partially mitigate the excess risk of PAD associated with higher GRS, albeit as a nonsignificant interaction. Several biomarkers in the lipid metabolism, hepatic/renal function, and systemic inflammation pathways collectively explained 13.3% (8.5%, 20.1%) of the association between weighted lifestyle score and PAD.

Conclusions: A favorable lifestyle was associated with lower risk of PAD among individuals with T2D, independent of genetic predisposition to PAD.

Citing Articles

Diabetes Mellitus in Kidney Transplant Recipients: New Horizons in Treatment.

Sanchez-Baya M, Bolufer M, Vazquez F, Alonso N, Masso E, Paul J J Clin Med. 2025; 14(4).

PMID: 40004579 PMC: 11856796. DOI: 10.3390/jcm14041048.


Comment on Rhee et al. Discrepancy Between Genetically Predicted and Observed BMI Predicts Incident Type 2 Diabetes. Diabetes Care 2024;47:1826-1833.

Huang B, Zhao K Diabetes Care. 2025; 48(3):e36.

PMID: 39977636 PMC: 11870282. DOI: 10.2337/dc24-2242.


TCF7L2 as a target of peripheral artery disease in patients with type 2 diabetes: A 2-sample Mendelian randomization and bioinformatics study.

Liu J, Liu X, Rao R, Li W Medicine (Baltimore). 2025; 104(7):e41431.

PMID: 39960897 PMC: 11835089. DOI: 10.1097/MD.0000000000041431.


A Review of Peripheral Artery Disease in Diabetic Patients in Sub-Saharan Africa.

Okunlola A, Ajao T, Karim A, Sabi M, Kolawole O, Ugwoke K Cureus. 2024; 16(9):e69808.

PMID: 39429407 PMC: 11491116. DOI: 10.7759/cureus.69808.


Association between grip strength, walking pace and incident peripheral artery disease: A prospective study of 430,886 UK biobank participants.

Liu D, Yang C, Liu G, Guo T, Liu S, Guo Y Int J Cardiol Cardiovasc Risk Prev. 2024; 23:200330.

PMID: 39309073 PMC: 11416223. DOI: 10.1016/j.ijcrp.2024.200330.